Loading…
Medicare Dental, Vision, and Hearing Benefit Act of 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
62pct
15d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Medicare Dental, Vision, and Hearing Benefit Act of 2017 This bill provides for Medicare coverage of dental, vision, and hearing care. With respect to such care, the bill establishes special payment rules, limitations, and coinsurance requirements.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2018 · fourth_quarter · Medicare/Medicaid
Medicare Part C (Medicare Advantage enrollement requirement) Medicare Part D (Medicare Part D prescriber enrollment requirement) H.R. 3111-Medicare Dental, Vision, and Hearing Benefit Act of 2017
Client expense: $530,000 · Firm income: Not reported
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Natl Drug Control Policy (NDCP), SENATE, Treasury, Dept of
2018 · fourth_quarter · Medicare/Medicaid
Hearing Aids. H.R. 3426, Medicare Hearing Aid Coverage Act: Proposal to provide Medicare coverage of hearing aids. Medicare Dental, Vision, and Hearing Coverage. H.R. 508, Seniors Have Eyes, Ears and Teeth Act and H.R. 3111, Medicare Dental, Vision, and Hearing Benefit Act of 2017: Proposals to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Medicare Observation Status. S. 568/H.R. 1421, Improving Access to Medicare Coverage Act of 2017: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Dementia and Alzheimers Disease. S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias. Generic Drug Introduction. S. 974/H.R. 2212, CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Opioid Treatment. H.R. 6, SUPPORT for Patients and Communities Act: Section 2005 proposals related to Medicare coverage of certain services furnished by opioid treatment programs. Medicare Beneficiary Equitable Relief. (No bill): Efforts to extend and make permanent the Centers for Medicare and Medicaid Services policy for equitable relief for select individuals currently or previously enrolled in Affordable Care Act Marketplace plans who delayed Medicare enrollment during their Initial Enrollment Period or during a qualifying Special Enrollment Period. Medicare Physician Payment. (No bill): Proposal to collapse the current five levels of payments for office visits into two levels. Medicare and Medicaid Protection. S. 3330, Medicare and Medicaid Protection Act: Proposed changes to budget reconciliation legislation affecting Medicare and Medicaid program protections. Medicaid Home and Community Based Services. H.R. 7217, IMPROVE Act/H.R. 695, Department of Defense Appropriations Act, 2018: Provisions to extend spousal impoverishment protections to Medicaid home and community based services, and to extend the demonstration program, Money Follows the Person, which provides funding to states to assist people requiring long term care services to stay in their homes. Medicare Prescription Drug Costs. (No bill): Proposals to reduce amount drug manufacturers must contribute to closing the donut hole in 2019. Medicare Prescription Drug Costs. H.R. 6505, Medicare Negotiation and Competitive Licensing Act of 2018: Proposal to allow the Secretary of Health and Human Services to pay another manufacturer to produce a drug in instances where a drug manufacturer fails to provide Medicare a reasonable price for the drug. Medicare Prescription Drug Costs. (No bill): Provisions of the United States-Mexico-Canada Agreement (formerly the North American Free Trade Agreement) addressing countries having expansive regulatory approval monopolies for biologic drugs and restrict the ability of Congress to reform patent laws that drive up drug costs for Medicare. Medicare Part B Drug Costs. (No bill): Proposals to reduce Medicare Part B drug costs by limiting Medicare payment when a drug price increase exceeds an inflation limit. Medicare Open Enrollment. (No bill): Proposals to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a way that is unbiased toward the traditional program. Medigap reform. (No bill): Proposals to extend Medigap guaranteed issue protections -requiring plans to extend coverage without regard to health status - to all beneficiaires with Medicare Advantage, to disabled beneficiaries under the age of 65 and to beneficiaries with Medigap plans C and F, which will stop taking new enrollees in 2020.
Client expense: $210,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Social Security Administration (SSA), Treasury, Dept of
2018 · third_quarter · Medicare/Medicaid
Hearing Health Care Services. S. 2575/H.R. 2276, Audiology Patient Choice Act of 2018: Proposal to expand access to hearing health care services for Medicare beneficiaries. Hearing Aids. H.R. 3426, Medicare Hearing Aid Coverage Act: Proposal to provide Medicare coverage of hearing aids. Medicare Dental, Vision, and Hearing Coverage. H.R. 508, Seniors Have Eyes, Ears and Teeth Act and H.R. 3111, Medicare Dental, Vision, and Hearing Benefit Act of 2017: Proposals to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Medicare Observation Status. S. 568/H.R. 1421, Improving Access to Medicare Coverage Act of 2017: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Dementia and Alzheimers. S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias. Alzheimers Disease. S. 2387/H.R. 4957, Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act of 2018: Proposal to aid Alzheimers disease suffers, their families and caregivers, including authorization of a cognitive impairment detection benefit in the Medicare annual wellness visit and initial preventive physical examination. Drug Price Negotiation. S. 2011/H.R. 4138, Medicare Drug Price Negotiation Act: Proposals to lower prescription drug prices in the Medicare Part D program, including allowing Medicare to negotiate directly with prescription drug manufacturers and requiring drug manufacturers to rebate to the federal government for drugs covered under Medicare Part D for low-income Medicare beneficiaries. Generic Drug Introduction. S. 974/H.R. 2212, CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Opioid Treatment. H.R. 6, SUPPORT for Patients and Communities Act: Section 2005 proposals related to Medicare coverage of certain services furnished by opioid treatment programs. Medicare Beneficiary Equitable Relief. (No bill): Efforts to extend and make permanent the Centers for Medicare and Medicaid Services policy for equitable relief for select individuals currently or previously enrolled in Marketplace plans who delayed Medicare enrollment during their Initial Enrollment Period or during a qualifying Special Enrollment Period. Medicare Physician Payment. (No bill): Proposal to collapse the current five levels of payments for office visits (Evaluation and Management) into two levels. Medicare and Medicaid Protection. S. 3330, Medicare and Medicaid Protection Act: Proposed changes to budget reconciliation legislation affecting Medicare and Medicaid program protections. Medicaid Protection. (No bill): Proposals requiring Medicaid recipients to work and ending homecare workers rights to make deductions from their pay for health care and union dues. Medicare Prescription Drug Costs. (May be attached to several legislative vehicles.) Proposals to reduce amount drug manufacturers must contribute to closing the donut hole. Medicare Prescription Drug Costs. S. 2553, Know the Lowest Price Act of 2018: Proposal to prohibit Medicare Advantage plans from putting clauses in contracts with pharmacists prohibiting them from disclosing to beneficiaries when a drug is less expensive if the beneficiary doesnt use his or her insurance. Medicare Part B Drug Costs. H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018: Proposal to reduce Medicare Part B drug costs by requiring Medicare to rebate to the government the amount by which a drug price increase exceeds an inflation limit. Medicare Open Enrollment. (No bill). Efforts to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a way that is unbiased toward the traditional program.
Client expense: $210,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Social Security Administration (SSA), Treasury, Dept of
2018 · second_quarter · Medicare/Medicaid
Hearing Health Care Services. S. 2575/H.R. 2276, Audiology Patient Choice Act of 2018: Proposal to expand access to hearing health care services for Medicare beneficiaries. Hearing Aids. H.R. 3426, Medicare Hearing Aid Coverage Act: Proposal to provide Medicare coverage of hearing aids. Medicare Dental, Vision, and Hearing Coverage. H.R. 508, Seniors Have Eyes, Ears and Teeth Act and H.R. 3111, Medicare Dental, Vision, and Hearing Benefit Act of 2017: Proposals to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Medicare Observation Status. S. 568/H.R. 1421, Improving Access to Medicare Coverage Act of 2017: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Opioid Treatment. S. 2704/H.R. 4097, Medicare Beneficiary Opioid Addiction Treatment Act: Proposal to provide for coverage of methadone under Medicare Part B. Dementia and Alzheimers. S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias; Alzheimers Disease. S. 2387/H.R. 4957, Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act of 2018: Proposal to aid Alzheimers disease suffers, their families and caregivers, including authorization of a cognitive impairment detection benefit in the Medicare annual wellness visit and initial preventive physical examination. Drug Price Negotiation. S. 2011/H.R. 4138, Medicare Drug Price Negotiation Act: Proposals to lower prescription drug prices in the Medicare Part D program, including allowing Medicare to negotiate directly with prescription drug manufacturers and requiring drug manufacturers to rebate to the federal government for drugs covered under Medicare Part D for low-income Medicare beneficiaries. Generic Drug Introduction. S. 974/H.R. 2212, CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Prescription Drug costs. S. 2553/H.R. 6144, the Know the Lowest Price Act: Proposal to prohibit health plans and pharmacy benefits managers from utilizing contract gag clauses prohibiting pharmacists from disclosing to consumers when it costs less to pay out-of-pocket for a prescription than it would using their insurance coverage. Medicare Part B Drug Costs . H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018: Proposal to reduce Medicare Part B drug costs by requiring Medicare to rebate to the government the amount by which a drug price increase exceeds an inflation limit. Medicare Beneficiary Education. (No bill): Efforts to improve the Centers for Medicare and Medicaid outreach and education during open enrollment.
Client expense: $260,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), President of the U.S., SENATE, Social Security Administration (SSA), Treasury, Dept of, Vice President of the U.S.
2018 · first_quarter · Medicare/Medicaid
2018 Medicare Open Enrollment (No bill). The Center for Medicare and Medicaid Services Administrations public outreach and education around the 2018 Medicare open enrollment. Medicare Dental, Vision, and Hearing Coverage. H.R. 508, Seniors Have Eyes, Ears and Teeth Act and H.R. 3111, Medicare Dental, Vision, and Hearing Benefit Act of 2017: Proposals to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Medicare Hearing Coverage. H.R. 3426, Medicare Hearing Aid Coverage Act: Proposal to provide Medicare coverage of hearing aids. Medicare Observation Status. S. 568, H.R. 1421, Improving Access to Medicare Coverage Act of 2017: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Beneficiary Enrollment Notification and Eligibility . S. 1909, H. R. 2575, Beneficiary Enrollment Notification and Eligibility Simplification Act: Proposals to improve Medicare Part B enrollment and to align Part B, Medicare Advantage and Part D rules. Opioid Treatment for Seniors. H.R. 5085, Expanding Access to Evidence-Based Opioid Treatment for Seniors Act of 2018: Proposal to require Medicare to recognize substance abuse treatment facilities as independent providers. Dementia and Alzheimers. S. 2076, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act), Proposal for applying a public health approach to combat Alzheimers disease and related dementias. Medicare Privatization (No bill). Proposals to transform traditional Medicare into a private insurance carrier program. Medicare Eligibility Age (No bill). Proposal to raise the eligibility age for Medicare from 65 to 67. National Survey of Older Americans Act Participants (No bill). Proposal to have the Administration for Community Living reinstate a demographic question on gender identity. Money Follows the Person (No bill). Proposal to reauthorize a demonstration that provides funding and support for states to transition individuals living in institutional care settings into settings that are more integrated with their communities. Alex M. Azars Nomination to head the Department of Health and Human Services (No bill). Questions pertaining to Mr. Azars positions on the Affordable Care Act, Medicaid block granting, and his background as a pharmaceutical executive. Medicare Part B Prices. H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018: Proposal to require drug manufacturers to rebate to the Secretary of Health and Human Services the amount by which a drug exceeds past prices above inflation. Drug Price Negotiation. S. 2011, H.R. 4138, Medicare Drug Price Negotiation Act: Proposals to lower prescription drug prices in the Medicare Part D program, including allowing Medicare to negotiate directly with prescription drug manufacturers. Requires drug manufacturers to provide a rebate to the federal government for drugs covered under Medicare Part D for low-income Medicare beneficiaries. Generic Drug Market Anticompetitive Behavior. S.974, H.R.2212, CREATES Act of 2017: Proposal to curb abuses by brand drug makers that prevent or delay generic drug manufacturers from getting sufficient samples of the brand drugs needed to obtain FDA approval, keeping generics off the market and driving up drug costs.
Client expense: $250,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), President of the U.S., SENATE, Social Security Administration (SSA), Treasury, Dept of, Vice President of the U.S.
2017 · third_quarter · Medicare/Medicaid
Medicare Dental, Vision, and Hearing Coverage. H.R. 508, Seniors Have Eyes, Ears and Teeth Act and H.R. 3111, Medicare Dental, Vision, and Hearing Benefit Act of 2017: Proposals to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Over-the-Counter Hearing Aids. S. 670/H.R. 1652, Over-the-Counter Hearing Aid Act of 2017: Proposal to provide access to more affordable hearing aids for adults with mild to moderate hearing loss. Medicare Observation Status. S. 568, H.R. 1421, Improving Access to Medicare Coverage Act of 2017: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Medicare Buy-in. S. 1742, Medicare at 55 Act: Proposal to provide an option for any citizen or permanent resident of the United States age 55 to 64 to buy into Medicare. Medicare Buy-in and Health Care Stabilization. H.R. 3748, the Medicare Buy-In and Health Care Stabilization Act: Proposals to create a Medicare buy-in option for Americans ages 50-64, to bolster stability in the health care marketplaces with common sense solutions and to bring down costs in the health care system through innovative ways reducing waste, fraud, and abuse. Medicare Expansion. S. 1804, Medicare for All Act: Proposal to establish a Medicare-for-all national health insurance program. Medicare Privatization. (No bill.) Proposals to transform traditional Medicare into a private insurance carrier program. Medicare Eligibility Age. (No bill.) Proposal to raise the eligibility age for Medicare from 65 to 67. Affordable Care Act (ACA) Repeal and Replace. Amendments to H. R. 1628, The American Health Care Act (AHCA): Provisions affecting the costs of private health insurance for older Americans under age 65, restructuring the Medicaid program and institutional and in-home long-term care services. Medicare and Medicaid Extenders. (No bill.) Proposals to make permanent expiring funding for community-based organizations to support outreach and enrollment to low-income Medicare beneficiaries, to extend the Medicare therapy caps exceptions process and to extend and improve Medicaid home and community-based services. Alzheimers Disease Patients and Family Caregivers. (No bill.) Proposal to have the Centers for Medicare and Medicaid Services assist people living with dementia, support family caregivers, strengthen clinical practice and reduce costs to federal and state health programs. Nursing Home Residents. (No bill.) Proposal to have the Centers for Medicare and Medicaid Services maintain existing regulations protecting nursing home residents from mandatory arbitration to settle disputes with a nursing facility. Marketplace Enrollees. (No bill.) Proposal to have the Centers for Medicare and Medicaid Services extend the time for an equitable-relief opportunity for certain individuals enrolled in Marketplace plans who delayed Medicare enrollment. Affordable Care Act Patient and Consumer Protections. (No bill.) Proposal to have the Department of Health and Human Services implement the final rule on Section 1557 which protects against discrimination based on age, race, color, national origin, limited English proficiency, disability or sex. Drug Pricing. S. 1131, H.R. 2439, Fair Drug Pricing Act: Proposal to require drug manufacturers to submit price justifications when increasing the cost of drugs by 10 percent or more a year. Drug Pricing. S. 771, Access to Affordable Prescription Drugs Act: Provisions to allow Medicare to negotiate prescription drugs; prohibit anti-competitive behavior between brand and generic drug makers; allow the importation of prescription drugs from licensed Canadian pharmacies. Drug Pricing. S. 469/H.R. 1245, the Affordable and Safe Prescription Drug Importation Act: Proposal to permit wholesalers, licensed pharmacists and individuals to import drugs from Canada. Drug Pricing. S. 348, the Prescription Drug and Health Improvement Act of 2017: Provisions directing the Secretary of Health and Human Services to negotiate prices for specialty drugs, drugs that account for high levels of spending, and those with dramatic price spikes. Drug Pricing. S. 974/H.R. 2212, the Creating and Restoring Equal Access to Equivalent Samples Act of 2017: Proposal to create a civil cause of action against manufacturers who abuse the Risk Evaluation and Mitigation Strategy (REMS) process by limiting access to samples generic makers need to produce drugs and create competition. Caregiving. S. 1028, RAISE Family Caregivers Act. Proposal to require the Secretary of Health and Human Services to develop a strategy to support family caregivers.
| Democratic |
| NJ |
| Bonnie Watson Coleman | Democratic | NJ |
| Brian Higgins | Democratic | NY |
| Chellie Pingree | Democratic | ME |
| Danny K. Davis | Democratic | IL |
| Doris O. Matsui | Democratic | CA |
| Earl Blumenauer | Democratic | OR |
| Eleanor Holmes Norton | Democratic | DC |
| Elijah E. Cummings | Democratic | MD |
| Grace F. Napolitano | Democratic | CA |
| Gwen Moore | Democratic | WI |
| James P. McGovern | Democratic | MA |
| James R. Langevin | Democratic | RI |
| Janice D. Schakowsky | Democratic | IL |
| John B. Larson | Democratic | CT |
| John Conyers, Jr. | Democratic | MI |
| John Garamendi | Democratic | CA |
| John Lewis | Democratic | GA |
| Joseph Crowley | Democratic | NY |
| Judy Chu | Democratic | CA |
| Linda T. Sánchez | Democratic | CA |
| Nanette Diaz Barragán | Democratic | CA |
| Raúl M. Grijalva | Democratic | AZ |
| Richard E. Neal | Democratic | MA |
| Ro Khanna | Democratic | CA |
| Rosa L. DeLauro | Democratic | CT |
| Terri A. Sewell | Democratic | AL |
| Zoe Lofgren | Democratic | CA |
Client expense: $220,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), President of the U.S., SENATE, Social Security Administration (SSA), Treasury, Dept of, Vice President of the U.S.